235 related articles for article (PubMed ID: 26479876)
1. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.
Schomaker M; Davies MA; Malateste K; Renner L; Sawry S; N'Gbeche S; Technau KG; Eboua F; Tanser F; Sygnaté-Sy H; Phiri S; Amorissani-Folquet M; Cox V; Koueta F; Chimbete C; Lawson-Evi A; Giddy J; Amani-Bosse C; Wood R; Egger M; Leroy V;
Epidemiology; 2016 Mar; 27(2):237-46. PubMed ID: 26479876
[TBL] [Abstract][Full Text] [Related]
2. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
[TBL] [Abstract][Full Text] [Related]
3. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.
Schomaker M; Leroy V; Wolfs T; Technau KG; Renner L; Judd A; Sawry S; Amorissani-Folquet M; Noguera-Julian A; Tanser F; Eboua F; Navarro ML; Chimbetete C; Amani-Bosse C; Warszawski J; Phiri S; N'Gbeche S; Cox V; Koueta F; Giddy J; Sygnaté-Sy H; Raben D; Chêne G; Davies MA;
Int J Epidemiol; 2017 Apr; 46(2):453-465. PubMed ID: 27342220
[TBL] [Abstract][Full Text] [Related]
4. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
[TBL] [Abstract][Full Text] [Related]
5. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
[TBL] [Abstract][Full Text] [Related]
6. Growth in HIV-infected children on long-term antiretroviral therapy.
Feucht UD; Van Bruwaene L; Becker PJ; Kruger M
Trop Med Int Health; 2016 May; 21(5):619-29. PubMed ID: 26914715
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
Bolton-Moore C; Mubiana-Mbewe M; Cantrell RA; Chintu N; Stringer EM; Chi BH; Sinkala M; Kankasa C; Wilson CM; Wilfert CM; Mwango A; Levy J; Abrams EJ; Bulterys M; Stringer JS
JAMA; 2007 Oct; 298(16):1888-99. PubMed ID: 17954540
[TBL] [Abstract][Full Text] [Related]
9. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.
Adjé-Touré C; Hanson DL; Talla-Nzussouo N; Borget MY; Kouadio LY; Tossou O; Fassinou P; Bissagnene E; Kadio A; Nolan ML; Nkengasong JN
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):911-7. PubMed ID: 18593341
[TBL] [Abstract][Full Text] [Related]
10. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
11. Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.
Jesson J; Koumakpaï S; Diagne NR; Amorissani-Folquet M; Kouéta F; Aka A; Lawson-Evi K; Dicko F; Kouakou K; Pety T; Renner L; Eboua T; Coffie PA; Desmonde S; Leroy V;
Pediatr Infect Dis J; 2015 Jul; 34(7):e159-68. PubMed ID: 25955835
[TBL] [Abstract][Full Text] [Related]
12. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M
HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
[TBL] [Abstract][Full Text] [Related]
13. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
14. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
[TBL] [Abstract][Full Text] [Related]
15. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
Fenner L; Brinkhof MW; Keiser O; Weigel R; Cornell M; Moultrie H; Prozesky H; Technau K; Eley B; Vaz P; Pascoe M; Giddy J; Van Cutsem G; Wood R; Egger M; Davies MA;
J Acquir Immune Defic Syndr; 2010 Aug; 54(5):524-32. PubMed ID: 20588185
[TBL] [Abstract][Full Text] [Related]
16. Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017.
Iyun V; Technau KG; Eley B; Rabie H; Boulle A; Fatti G; Egger M; Tanser F; Wood R; Fairlie L; Cotton MF; Davies MA
Pediatr Infect Dis J; 2020 Feb; 39(2):127-133. PubMed ID: 31725119
[TBL] [Abstract][Full Text] [Related]
17. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
Gabillard D; Lewden C; Ndoye I; Moh R; Segeral O; Tonwe-Gold B; Etard JF; Pagnaroat M; Fournier-Nicolle I; Eholié S; Konate I; Minga A; Mpoudi-Ngole E; Koulla-Shiro S; Zannou DM; Anglaret X; Laurent C;
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):555-61. PubMed ID: 23274931
[TBL] [Abstract][Full Text] [Related]
18. Growth in the first 5 years after antiretroviral therapy initiation among HIV-infected children in the IeDEA West African Pediatric Cohort.
Jesson J; Ephoevi-Ga A; Desmonde S; Ake-Assi MH; D'Almeida M; Sy HS; Malateste K; Amorissani-Folquet M; Dicko F; Kouadio K; Renner L; Leroy V;
Trop Med Int Health; 2019 Jun; 24(6):775-785. PubMed ID: 30945378
[TBL] [Abstract][Full Text] [Related]
19. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
Newell ML; Patel D; Goetghebuer T; Thorne C;
J Infect Dis; 2006 Apr; 193(7):954-62. PubMed ID: 16518757
[TBL] [Abstract][Full Text] [Related]
20. Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi.
Weigel R; Phiri S; Chiputula F; Gumulira J; Brinkhof M; Gsponer T; Tweya H; Egger M; Keiser O
Trop Med Int Health; 2010 Aug; 15(8):934-44. PubMed ID: 20561308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
